蜜桃传媒 Researcher鈥檚 Global Team Wins $25 Million Cancer Grand Challenges Award
Focusing on cancer inequities, Team SAMBAI, led by Dr. Melissa Davis, is the only winning team in the U.S. led by an African American woman.
ATLANTA, GA 鈥� March 6, 2024 鈥� 蜜桃传媒 School of Medicine (蜜桃传媒) today announced Team SAMBAI, a global team led by Melissa B. Davis, PhD, director of the 蜜桃传媒 Institute of Translational Genomic Medicine, has been awarded a $25 million grant funded by Cancer Research UK and the National Cancer Institute, through Cancer Grand Challenges, to address cancer disparities in populations of African ancestry, becoming the first Cancer Grand Challenge awardee to focus on cancer inequities.
Called Team SAMBAI (Societal, Ancestry, Molecular and Biological Analyses of Inequalities), Dr. Davis is leading an interdisciplinary research group from the United States, Ghana, South Africa, and the United Kingdom. The award not only marks the first one to focus on health disparities and to be led by an African American woman, but it is also the first one awarded to a researcher at a Historically Black Medical School and is the first one given to a host institution in 蜜桃传媒鈥檚 home state of Georgia.
鈥淲e are so incredibly proud of Dr. Davis鈥� leadership in directing the effort to create a truly historic and precedent setting winning proposal to Cancer Grand Challenges that holds the potential to have a tremendous impact on how we treat cancer for people with African ancestry,鈥� said 蜜桃传媒 President and CEO Dr. Valerie Montgomery Rice. 鈥淔or nearly 50 years, the driving mission of 蜜桃传媒 School of Medicine has been to address health inequities for communities of color, and we are honored to have the unique opportunity to carry that mission forward in partnership with Cancer Grand Challenges.鈥�
鈥淚 want to extend my appreciation to Cancer Research UK, the National Cancer Institute, Cancer Grand Challenges, my Team SAMBAI colleagues around the world, and my 蜜桃传媒 School of Medicine family on being selected one of five world-class global research teams to win this award,鈥� said Dr. Davis. 鈥淲e are looking forward to engaging into what we hope will be groundbreaking research that will shift the paradigm for cancer inequity amongst people of African descent and hopefully helping to save lives in the future.鈥�
Team SAMBAI Members:
- Melissa Davis, Team Lead, 蜜桃传媒 School of Medicine, United States
- Yaw Bediako, Yemaachi Biotech, Ghana
- Tiffany Carson, Moffitt Cancer Center, United States
- Isidro Cortes Ciriano, European Molecular Biology Laboratory, United Kingdom
- Zodwa Dlamini, University of Pretoria, South Africa
- Olivier Elemento, Cornell University, United States
- Rick Fairley, TOUCH, The Black Breast Cancer Alliance, United States
- Fieke Froeling, University of Glasgow, United Kingdom
- Marcin Imielinski, New York University, United States
- Sheeba Irshad, King鈥檚 College London, United Kingdom
- Lauren McCullough, Emory University, United States
- Gary Miller, Columbia University, United States
- Nigel Mongan, University of Nottingham, United Kingdom
- Nicolas Robine, New York Genome Center, United States
- Clayton Yates, John Hopkins University, United States
The Team SAMBAI proposal integrates social determinants of health, environmental exposures, genetic contributions, and tumor biology to understand the complex interactions between genetics, environment, and social factors in cancer outcomes. The proposal also highlights the importance of patient partnership, advocacy, and support in addressing cancer disparities.
The proposal also focuses on breast cancer, particularly among Black women. While Black women have a slightly lower incidence rate of breast cancer compared to White women, they are more frequently diagnosed with advanced disease and have a higher incidence of aggressive forms of breast cancer, such as estrogen receptor (ER) negative (Triple-Negative) disease. This contributes to racial disparities in breast cancer outcomes.
鈥淭ogether with our network of visionary partners and research leaders, Cancer Grand Challenges unites the world's brightest minds across boundaries and disciplines and aims to overcome cancer鈥檚 toughest problems,鈥� said Dr. David Scott, Director of Cancer Grand Challenges. 鈥淲ith this investment, our largest to date, we continue to grow our global research community, and fund new teams that have the potential to surface discoveries that could positively impact cancer outcomes.鈥�
Now in its fourth funding round, this year Cancer Grand Challenges funded five global teams providing up to $25 million in grants per team over five years for a wide range of research projects including cancer inequities, early-onset cancers, solid tumors in children and T-cell receptors.
For more information on Team SAMBAI, its members, and their approach to tackling the cancer inequities challenge, visit .
About 蜜桃传媒 School of Medicine
Founded in 1975, 蜜桃传媒 School of Medicine (蜜桃传媒) is among the nation's leading educators of primary care physicians, biomedical scientists, and public health professionals. An independent and private historically-Black medical school, 蜜桃传媒 was recognized by the Annals of Internal Medicine as the nation's number one medical school in fulfilling a social mission 鈥� leading the creation and advancement of health equity to achieve health justice. 蜜桃传媒 School of Medicine's faculty and alumni are noted for excellence in teaching, research, and public policy, as well as exceptional patient care. 蜜桃传媒 is accredited by the Commission on Colleges of the Southern Association of Colleges and Schools to award doctoral and master's degrees. To learn more about programs and donate today, please visit www.msm.edu or call 404-752-1500.
About Cancer Grand Challenges
Co-founded in 2020 by two of the largest funders of cancer research in the world: Cancer Research UK and the National Cancer Institute in the US, Cancer Grand Challenges supports a global community of world-class, interdisciplinary teams to come together, think differently and take on some of cancer鈥檚 toughest challenges. These are the obstacles that continue to impede progress and no one scientist, institution or country will be able to solve them alone. With awards of up to $25M, Cancer Grand Challenges teams are empowered to rise above the traditional boundaries of geography and discipline to make the progress against cancer we urgently need.
Contact
Jamille Bradfield
Director, External Communications, Media Relations & Crisis Communications
蜜桃传媒 School of Medicine
jbradfield@msm.edu